| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 11/21/2001 | CN1322535A Recipe and preparation of hot compressing Chinese herbal medicine |
| 11/21/2001 | CN1322532A Application of staphyococcin Aureus in preparing medicine for osteoporosis |
| 11/21/2001 | CN1322523A External-use Mayroxicam gel agent and its preparation |
| 11/21/2001 | CN1075062C 乙酸衍生物 Acetic acid derivatives |
| 11/21/2001 | CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same |
| 11/20/2001 | US6320054 Thiazole derivatives |
| 11/20/2001 | US6320022 Adrenomedullin peptides |
| 11/20/2001 | US6319922 Propanoic acid derivatives |
| 11/20/2001 | US6319921 Aromatic heterocyclic compound as antiinflammatory agents |
| 11/20/2001 | US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
| 11/20/2001 | US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) |
| 11/15/2001 | WO2001085986A2 Phosphatidyl inositol 3-kinase delta binding partner |
| 11/15/2001 | WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 11/15/2001 | WO2001085942A2 Cytoskeleton-associated proteins |
| 11/15/2001 | WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 11/15/2001 | WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | WO2001085729A1 Novel vitronectin receptor antagonists |
| 11/15/2001 | WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 11/15/2001 | WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 11/15/2001 | WO2001085671A2 Anthranyl amides and their use as medicaments |
| 11/15/2001 | WO2001085217A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 11/15/2001 | WO2001085194A1 Method and composition for the treatment of angiogenesis |
| 11/15/2001 | WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 11/15/2001 | WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF |
| 11/15/2001 | WO2001084963A1 Edible composition containing micronised nacre powder |
| 11/15/2001 | WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 11/15/2001 | WO2001032878A3 A novel polypeptide hormone phosphatonin |
| 11/15/2001 | WO2000050872A9 A system for cell-based screening |
| 11/15/2001 | US20010041743 Prostaglandins |
| 11/15/2001 | US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 11/15/2001 | US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production |
| 11/15/2001 | US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles |
| 11/15/2001 | US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes |
| 11/15/2001 | US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 11/15/2001 | US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts |
| 11/15/2001 | US20010041673 A purine derivative or salt, useful for treating heart related diseases including congestive heart failure in mammals, particularly in human |
| 11/15/2001 | DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus |
| 11/15/2001 | CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof |
| 11/15/2001 | CA2409759A1 Method and composition for the treatment of angiogenesis |
| 11/15/2001 | CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| 11/15/2001 | CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 11/15/2001 | CA2408571A1 Mammalian receptor proteins; related reagents and methods |
| 11/15/2001 | CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof |
| 11/15/2001 | CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 11/15/2001 | CA2408293A1 Novel vitronectin receptor antagonists |
| 11/15/2001 | CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 11/15/2001 | CA2407850A1 Cytoskeleton-associated proteins |
| 11/15/2001 | CA2407817A1 Anthranilamides and their use as pharmaceutical agents |
| 11/14/2001 | EP1153618A1 Use of oxidized cellulose as free radical scavenger |
| 11/14/2001 | EP1153607A2 Growth hormone for the treatment of joint inflammation |
| 11/14/2001 | EP1153121A2 Secreted proteins and polynucleotides encoding them |
| 11/14/2001 | EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation |
| 11/14/2001 | EP1153034A1 Growth hormone secretagogues |
| 11/14/2001 | EP1153024A1 2-amino-6-anilino-purines and their use as medicaments |
| 11/14/2001 | EP1153022A1 Prothease inhibitors |
| 11/14/2001 | EP1153015A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 11/14/2001 | EP1153014A2 Beta-alanine derivatives |
| 11/14/2001 | EP1152770A1 Small peptides and methods for treatment of asthma and inflammation |
| 11/14/2001 | EP1152761A2 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 11/14/2001 | EP1152760A1 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 11/14/2001 | EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 11/14/2001 | EP1152757A2 Connective tissue softening |
| 11/14/2001 | EP0980250B1 Plant extracts for the treatment of increased bone resorption |
| 11/14/2001 | EP0762883B1 Pyridylbisphosphonates for use as a therapeutical agent |
| 11/14/2001 | EP0688360B1 Bone stimulating factor |
| 11/14/2001 | CN1322246A Restin and methods of use thereof |
| 11/14/2001 | CN1322243A Urate oxidase |
| 11/14/2001 | CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists |
| 11/14/2001 | CN1322194A Substituted phenyl derivatives, their preparation and use |
| 11/14/2001 | CN1322133A Vitronectin receptor antagonists |
| 11/14/2001 | CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them |
| 11/14/2001 | CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them |
| 11/14/2001 | CN1321505A Jingyunling medicine for treating cervical spondylopathy |
| 11/14/2001 | CN1321504A Jingzhuikang medicine for curing cervical spondylopathy |
| 11/14/2001 | CN1321503A Bitong capsule for treating numbness |
| 11/14/2001 | CN1321500A Method for preventing and curing diseases by using kakonein preparation |
| 11/14/2001 | CN1321493A Chinese medicine capsule for curing prolapse of lumber intervertebral disc and preparing method thereof |
| 11/14/2001 | CN1321492A Medicine for curing necrosis of femoral head |
| 11/14/2001 | CN1074679C Chinese medicine for treating bone fracture |
| 11/14/2001 | CN1074676C Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof |
| 11/14/2001 | CN1074670C Medicine for treatment of rheumatism and arthritis |
| 11/14/2001 | CN1074665C Method and medical agent for diagnosis and/or therapy of arthritis |
| 11/13/2001 | US6316648 Purified 5,6,15-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid; anticarcinogenic and antiproliferative agents |
| 11/13/2001 | US6316642 For therapy of osteoporosis and psoriasis, as anticancer agent |
| 11/13/2001 | US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia |
| 11/13/2001 | US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron |
| 11/13/2001 | US6316478 IL-8 receptor antagonists |
| 11/13/2001 | US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors |
| 11/13/2001 | US6316471 Treating inflammatory or autoimmune diseases |
| 11/13/2001 | US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors |
| 11/13/2001 | US6316464 P38 MAP kinase inhibitors |
| 11/13/2001 | US6316460 Containing a heptenoic acid derivative and a tribasic phosphate salt as a stabilizer; hmg-coa reductase inhibitor |
| 11/13/2001 | US6316444 SRC kinase inhibitor compounds |
| 11/13/2001 | US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors |
| 11/13/2001 | US6316410 Amino acid sequences of peptide hormones |
| 11/13/2001 | US6316408 Methods of use for osetoprotegerin binding protein receptors |
| 11/12/2001 | CA2347442A1 Free radical scavenging compositions |
| 11/11/2001 | CA2345787A1 Biocompatible macromers |
| 11/08/2001 | WO2001083775A2 Proteases |
| 11/08/2001 | WO2001083713A2 The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same |